These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35170287)

  • 1. COVID-19 vaccination including 198 patients with history of severe anaphylactic reaction - own observations.
    Wentrys Ł; Stopyra L
    Przegl Epidemiol; 2021; 75(3):315-325. PubMed ID: 35170287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaphylaxis is a rare reaction in COVID-19 vaccination.
    Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
    J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.
    Abi Zeid Daou C; Natout MA; El Hadi N
    J Med Virol; 2021 Oct; 93(10):6027-6029. PubMed ID: 34050949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
    Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
    JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.
    Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P
    Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
    ;
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pfizer/BioNtech BNT162b2: adverse events and insights from an Australian mass vaccination clinic for COVID-19.
    Halder A; Imamura H; Condon S; Boroughs K; Nilsson SC; Anderson T; Caterson ID
    Intern Med J; 2022 Jan; 52(1):121-124. PubMed ID: 35060290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
    Gordon SF; Clothier HJ; Morgan H; Buttery JP; Phuong LK; Monagle P; Chunilal S; Wood EM; Tran H; Szer J; Crawford NW;
    Vaccine; 2021 Nov; 39(48):7052-7057. PubMed ID: 34756770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines.
    Sokolowska M; Eiwegger T; Ollert M; Torres MJ; Barber D; Del Giacco S; Jutel M; Nadeau KC; Palomares O; Rabin RL; Riggioni C; Vieths S; Agache I; Shamji MH
    Allergy; 2021 Jun; 76(6):1629-1639. PubMed ID: 33452689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers.
    Maruyama A; Sawa T; Teramukai S; Katoh N
    J Infect Chemother; 2022 Jul; 28(7):934-942. PubMed ID: 35361536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis.
    Alhumaid S; Al Mutair A; Al Alawi Z; Rabaan AA; Tirupathi R; Alomari MA; Alshakhes AS; Alshawi AM; Ahmed GY; Almusabeh HM; Alghareeb TT; Alghuwainem AA; Alsulaiman ZA; Alabdulmuhsin MA; AlBuwaidi EA; Dukhi AKB; Mufti HN; Al-Qahtani M; Dhama K; Al-Tawfiq JA; Al-Omari A
    Allergy Asthma Clin Immunol; 2021 Oct; 17(1):109. PubMed ID: 34656181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2.
    Sprute R; Schumacher S; Pauls M; Pauls W; Cornely OA
    Drugs R D; 2021 Dec; 21(4):371-374. PubMed ID: 34351606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
    Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K
    Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.
    Patel GB; Chhiba KD; Chen MM; Guo A; Watts MM; Cullen J; Bochner BS; Grammer LC; Greenberger PA; Saltoun CA; Stevens WW; Kuang FL; Peters AT
    Allergy Asthma Proc; 2021 Nov; 42(6):515-521. PubMed ID: 34871159
    [No Abstract]   [Full Text] [Related]  

  • 17. Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel.
    Anis E; Preis SA; Cedar N; Tal Y; Hershkowitz I; Hershko AY
    J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2969-2976. PubMed ID: 35872216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine-a case report.
    Consoli S; Dono F; Evangelista G; D'Apolito M; Travaglini D; Onofrj M; Bonanni L
    Neurol Sci; 2022 Feb; 43(2):767-770. PubMed ID: 34807361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.
    Desai AP; Desai AP; Loomis GJ
    Vaccine; 2021 Jul; 39(32):4407-4409. PubMed ID: 34215453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site.
    Myles IA; Vinciguerra JS; Premus RT
    Vaccine; 2021 Jul; 39(32):4404-4406. PubMed ID: 34217573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.